VANDERLOCHT, Joris

Email Alert RSS Feed

Profile

Full Name
VANDERLOCHT, Joris
Email
joris.vanderlocht@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 1-20 of 20 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)TypeCat.
12021Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemicsLIBIN, Pieter ; Willem, Lander; Verstraeten, Timothy; TORNERI, Andrea ; VANDERLOCHT, Joris ; HENS, Niel Journal ContributionA1
22020A prospect on the use of antiviral drugs to control local outbreaks of COVID-19TORNERI, Andrea ; LIBIN, Pieter ; VANDERLOCHT, Joris ; Vandamme, Anne-Mieke; Neyts, Johan; HENS, Niel Journal ContributionA1
32015Comment on "Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patients" by Levy et al. J. Neuroimmunol. 2015 Jan 15; 278C:85-89.VANDERLOCHT, Joris ; HELLINGS, Niels Journal ContributionA1
42008Leukaemia inhibitory factor induces an anti-apoptotic response in oligodendrocytes through Akt-phosphorylation and upregulation of 14-3-3SLAETS, Leen ; DUMONT, Debora ; VANDERLOCHT, Joris ; NOBEN, Jean-Paul ; Leprince, P.; ROBBEN, Johan ; HENDRIKS, Jerome ; STINISSEN, Piet ; HELLINGS, Niels Journal ContributionM
52008Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imagingBAETEN, Kurt ; HENDRIKS, Jerome ; HELLINGS, Niels ; THEUNISSEN, Evi ; VANDERLOCHT, Joris ; DE RYCK, Leen ; GELAN, Jan ; STINISSEN, Piet ; ADRIAENSENS, Peter Journal ContributionA1
62008Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3SLAETS, Leen ; DUMONT, Debora ; VANDERLOCHT, Joris ; NOBEN, Jean-Paul ; Leprince, P.; ROBBEN, Johan ; HENDRIKS, Jerome ; STINISSEN, Piet ; HELLINGS, Niels Journal ContributionA1
72007The ambivalent nature of T-cell infiltration in the central nervous system of patients with multiple sclerosisVANDERLOCHT, Joris ; HELLINGS, Niels ; HENDRIKS, Jerome ; STINISSEN, Piet Journal ContributionA1
82007Leukemia inhibitory factor-mediated protection of oligodendrocytes: implications for multiple sclerosisSLAETS, Leen ; DUMONT, Debora ; VANDERLOCHT, Joris ; Leprince, P.; ROBBEN, Johan ; HENDRIKS, Jerome ; STINISSEN, Piet ; HELLINGS, Niels Journal ContributionM
92007Characterization of mature rat oligodendrocytes: a proteomic approachDUMONT, Debora ; NOBEN, Jean-Paul ; MOREELS, Marjan ; VANDERLOCHT, Joris ; HELLINGS, Niels ; VANDENABEELE, Frank ; LAMBRICHTS, Ivo ; STINISSEN, Piet ; ROBBEN, Johan Journal ContributionA1
102007Immune mediated protection in multiple sclerosis: A role for neurokines in oligodendrocyte survival and macrophage modulationHELLINGS, Niels ; HENDRIKS, Jerome ; CARMANS, Sofie ; SLAETS, Leen ; DUMONT, Debora ; VANDERLOCHT, Joris ; STINISSEN, Piet Journal ContributionM
112006No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosisVANDERLOCHT, Joris ; BURZYKOWSKI, Tomasz ; SOMERS, Veerle ; STINISSEN, Piet ; HELLINGS, Niels Journal ContributionA1
122006A Role for Leukemia Inhibitory Factor in Multiple Sclerosis: Implications for Immune-mediated Protection in the Central Nervous SystemVANDERLOCHT, Joris Theses and DissertationsT1
132006Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-α-induced oligodendrocyte apoptosisVANDERLOCHT, Joris ; HELLINGS, Niels ; HENDRIKS, Jerome ; VANDENABEELE, Frank ; MOREELS, Marjan ; BUNTINX, Mieke ; Hoekstra, D.; Antel, J.; STINISSEN, Piet Journal ContributionA1
142006Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controlsVANDERLOCHT, Joris ; HENDRIKS, Jerome ; VENKEN, Koen ; STINISSEN, Piet ; HELLINGS, Niels Journal ContributionA1
152006Effects of IFN-beta, leptin and sinivastatin on LIF secretion by T lymphocytes of MS patients and healthy controlsVANDERLOCHT, Joris ; HENDRIKS, Jerome ; VENKEN, Koen ; STINISSEN, Piet ; HELLINGS, Niels Journal ContributionM
162006Current trends in multiple sclerosis research: an update on pathogenic conceptsVANDERLOCHT, Joris ; HELLINGS, Niels ; HENDRIKS, Jerome ; STINISSEN, Piet Journal ContributionA1
172006Influence of leukaemia inhibitory factor on macrophage function in vitro and during experimental autoimmune encephalomyelitisHENDRIKS, Jerome ; HELLINGS, Niels ; VANDERLOCHT, Joris ; STINISSEN, Piet Journal ContributionM
182004Leukemia inhibitory factor is produced by myelin reactive T-cells and protects against cytokine induced oligodendrocyte cell deathVANDERLOCHT, Joris ; HELLINGS, Niels ; VANDENABEELE, Frank ; MOREELS, Marjan ; Antel, J.; RAUS, Jef ; STINISSEN, Piet Journal ContributionM
192003Potential role for neuropoietic factors in protecting oligodendrocytes from cytokine induced damageVANDERLOCHT, Joris ; HELLINGS, Niels ; Dreesen, E; BUNTINX, Mieke ; DE RYCK, Leen ; RAUS, Jef ; STINISSEN, Piet Journal ContributionM
202003Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: Morphology and oligodendrocyte-specific gene expressionBUNTINX, Mieke ; VANDERLOCHT, Joris ; HELLINGS, Niels ; VANDENABEELE, Frank ; LAMBRICHTS, Ivo ; RAUS, Jef ; AMELOOT, Marcel ; STINISSEN, Piet ; STEELS, Paul Journal ContributionA1